Aviva PLC Edwards Lifesciences Corp Transaction History

Aviva PLC

$34.3 Billion
Q2 2024

A detailed history of Aviva PLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Aviva PLC holds 565,347 shares of EW stock, worth $37 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

565,347

Previous 392,344 44.09%

Holding current value

$37 Million

Previous $37.5 Million 39.29%

% of portfolio

0.15%

Previous 0.13%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$84.3 - $94.31 $14.6 Million - $16.3 Million	173,003 Added 44.09%	565,347 $52.2 Million
Q1 2024 May 14, 2024	SELL	$72.54 - $95.56 $7.44 Million - $9.8 Million	-102,590 Reduced 20.73%	392,344 $37.5 Million
Q4 2023 Feb 09, 2024	BUY	$61.71 - $77.76 $3.82 Million - $4.82 Million	61,951 Added 14.31%	494,934 $37.7 Million
Q3 2023 Nov 13, 2023	BUY	$69.28 - $93.38 $1.39 Million - $1.87 Million	19,992 Added 4.84%	432,983 $30 Million
Q2 2023 Aug 10, 2023	SELL	$81.41 - $94.33 $540,073 - $625,785	-6,634 Reduced 1.58%	412,991 $39 Million
Q1 2023 May 12, 2023	BUY	$74.26 - $84.51 $5.21 Million - $5.93 Million	70,129 Added 20.07%	419,625 $34.7 Million
Q4 2022 Feb 09, 2023	BUY	$68.3 - $87.44 $3.73 Million - $4.77 Million	54,585 Added 18.51%	349,496 $26.1 Million
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $65,896 - $85,832	-800 Reduced 0.27%	294,911 $24.4 Million
Q2 2022 Aug 04, 2022	BUY	$86.5 - $128.27 $1.15 Million - $1.71 Million	13,343 Added 4.73%	295,711 $28.1 Million
Q1 2022 May 13, 2022	SELL	$101.96 - $128.34 $41.3 Million - $52 Million	-404,882 Reduced 58.91%	282,368 $33.2 Million
Q4 2021 Feb 10, 2022	SELL	$106.37 - $130.68 $5.65 Million - $6.94 Million	-53,096 Reduced 7.17%	687,250 $89 Million
Q3 2021 Nov 12, 2021	BUY	$102.91 - $122.75 $2.17 Million - $2.58 Million	21,052 Added 2.93%	740,346 $83.8 Million
Q2 2021 Aug 10, 2021	BUY	$83.84 - $104.76 $1.19 Million - $1.49 Million	14,181 Added 2.01%	719,294 $74.5 Million
Q1 2021 May 13, 2021	BUY	$78.68 - $90.67 $26,987 - $31,099	343 Added 0.05%	705,113 $59 Million
Q4 2020 Feb 10, 2021	BUY	$71.69 - $91.23 $1.51 Million - $1.92 Million	21,086 Added 3.08%	704,770 $64.3 Million
Q3 2020 Nov 12, 2020	BUY	$67.19 - $87.44 $643,747 - $837,762	9,581 Added 1.42%	683,684 $54.6 Million
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $25.9 Million - $34.7 Million	450,488 Added 201.46%	674,103 $46.6 Million
Q1 2020 May 14, 2020	BUY	$52.41 - $81.0 $2.01 Million - $3.1 Million	38,288 Added 20.66%	223,615 $42.2 Million
Q4 2019 Feb 10, 2020	SELL	$71.7 - $82.09 $1.08 Million - $1.24 Million	-15,047 Reduced 7.51%	185,327 $43.2 Million
Q3 2019 Nov 12, 2019	BUY	$61.55 - $75.43 $4.98 Million - $6.1 Million	80,872 Added 67.67%	200,374 $44.1 Million
Q2 2019 Jul 30, 2019	SELL	$55.74 - $64.41 $111,368 - $128,691	-1,998 Reduced 1.64%	119,502 $22.1 Million
Q1 2019 May 14, 2019	SELL	$47.89 - $64.05 $2.7 Million - $3.61 Million	-56,332 Reduced 31.68%	121,500 $23.2 Million
Q4 2018 Feb 12, 2019	SELL	$46.41 - $56.94 $881,604 - $1.08 Million	-18,996 Reduced 9.65%	177,832 $27.2 Million
Q3 2018 Nov 13, 2018	SELL	$45.7 - $58.03 $342,521 - $434,934	-7,495 Reduced 3.67%	196,828 $34.3 Million
Q2 2018 Aug 01, 2018	SELL	$42.45 - $51.3 $110,157 - $133,123	-2,595 Reduced 1.25%	204,323 $29.7 Million
Q1 2018 May 14, 2018	SELL	$37.19 - $47.45 $407,453 - $519,862	-10,956 Reduced 5.03%	206,918 $28.9 Million
Q4 2017 Feb 13, 2018	SELL	$33.79 - $39.39 $426,801 - $497,535	-12,631 Reduced 5.48%	217,874 $24.6 Million
Q3 2017 Nov 13, 2017	BUY	$36.29 - $38.83 $134,127 - $143,515	3,696 Added 1.63%	230,505 $25.2 Million
Q2 2017 Aug 07, 2017	BUY	N/A	226,809	226,809 $26.8 Million

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.

Account